Share this article
Share this article
MINNEAPOLIS and AUSTIN, Texas, March 3, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Asuragen, Inc. for initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones. The transaction will be financed through a combination of cash on hand and an existing revolving line of credit. Bio-Techne anticipates the acquisition to close in the fourth quarter of its fiscal 2021.
Founded in 2006, Asuragen is headquartered in Austin, Texas and is a leader in the development, manufacturing and commercialization of genetic carrier screening and oncology testing kits. Asuragen s products leverage proprietary chemistries which can be used on widely available platforms
Share this article
Share this article
LYNDHURST, N.J., March 1, 2021 /PRNewswire/ CCA Industries, Inc. (OTC: CAWW), announced today its results for the year ended November 30, 2020. The results can be found on the chart below.
Net loss was $127,477 for the year ended November 30, 2020 as compared to net income of $554,462 for the year ended November 30, 2019. Lance Funston, Chief Executive Officer commented, The past year has been a difficult environment due to the COVID pandemic which had a negative effect on foot traffic and sales at major retailers. Internet based sales increased dramatically in fiscal 2020 which helped blunt some of the impact. We are continuing our focus on internet-based sales while also reducing our overhead to meet the challenge presented to us. The Company expects that as the retail environment recovers from the pandemic in fiscal 2021, our sales will increase.
CCA Industries, Inc Reports Financial Results for Year Ended November 30, 2020 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.